A Duplex CRISPR-Cas9 Ribonucleoprotein Nanomedicine for Colorectal Cancer Gene Therapy

Signatures of mutational processes in human cancer

Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660

Wnt/β-Catenin Signaling in Development and Disease

Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568

CRISPR-Cas guides the future of genetic engineering

Knott, G. J., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aat5011 · Cited by 1,410

Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor

Janes, M. R., Zhang, J., Li, L.-S., Hansen, R., Peters, U., Guo, X., Chen, Y., Babbar, A., Firdaus, S. J., Darjania, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.006 · Cited by 1,172

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair

Lee, K., Conboy, M., Park, H. M., Jiang, F., Kim, H. J., Dewitt, M. A., Mackley, V. A., Chang, K., Rao, A., Skinner, C., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0137-2 · Cited by 755

Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10

Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0327-9 · Cited by 707

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications

Liu, C., Zhang, L., Liu, H., & Cheng, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.012 · Cited by 607

Semi‐Automated Synthesis and Screening of a Large Library of Degradable Cationic Polymers for Gene Delivery

Anderson, D. G., Lynn, D. M., & Langer, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200351244 · Cited by 506

Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

Zheng, D.-W., Dong, X., Pan, P., Chen, K.-W., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0423-2 · Cited by 495

The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis

Chung, D. C. (2000) · Gastroenterology · doi:10.1053/gast.2000.16507 · Cited by 411

Invasion and metastasis in cancer: molecular insights and therapeutic targets

Li, Y., Liu, F., Cai, Q., Deng, L., Ouyang, Q., Zhang, X. H.-F., & Zheng, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02148-4 · Cited by 314

CRISPR/Cas9 systems: Delivery technologies and biomedical applications

Du, Y., Liu, Y., Hu, J., Peng, X., & Liu, Z. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100854 · Cited by 140

Bacterial protoplast-derived nanovesicles carrying CRISPR-Cas9 tools re-educate tumor-associated macrophages for enhanced cancer immunotherapy

Zhao, M., Cheng, X., Shao, P., Yao, D., Wu, Y., Xiao, L., Cui, Z., Sun, X., Gao, C., Chen, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44941-9 · Cited by 92

Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics

Hamdy, N. Μ., Zaki, M. B., Rizk, N. I., Abdelmaksoud, N. M., Abd‐Elmawla, M. A., Abdelhamid, R., & Abulsoud, A. I. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122946 · Cited by 92

Dual-responsive nanocarriers for efficient cytosolic protein delivery and CRISPR-Cas9 gene therapy of inflammatory skin disorders

Tan, E., Wan, T. Y., Pan, Q., Duan, J., Zhang, S., Wang, R., Gao, P., Lv, J., Wang, H., Li, D., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl4336 · Cited by 69

CRISPR-Cas12a-regulated DNA adsorption and metallization on MXenes as enhanced enzyme mimics for sensitive colorimetric detection of hepatitis B virus DNA

Tao, Y., Yi, K., Wang, H., Kim, H., Li, K., Zhu, X., & Li, M. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.01.038 · Cited by 68

Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy

Yi, K., Kong, H., Lao, Y., Li, D., Mintz, R. L., Fang, T., Chen, G., Tao, Y., Li, M., & Ding, J. (2023) · Advanced Materials · doi:10.1002/adma.202300665 · Cited by 66

Blocking the WNT/β-catenin pathway in cancer treatment:pharmacological targets and drug therapeutic potential

Zhao, X., Ma, Y., Luo, J., Xu, K., Tian, P., Lu, C., & Song, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35989 · Cited by 58

A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy

Yi, K., Kong, H., Zheng, C., Zhuo, C., Jin, Y., Zhong, Q., Mintz, R. L., Ju, E., Wang, H., Lv, S., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122349 · Cited by 49

Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing

Chen, Y., & Yuan, P. (2023) · Accounts of Chemical Research · doi:10.1021/acs.accounts.3c00279 · Cited by 48

Toward Gene Transfer Nanoparticles as Therapeutics

Kavanagh, E. W., & Green, J. J. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102145 · Cited by 47

Oral Microto-Nano Genome-Editing System Enabling Targeted Delivery and Conditional Activation of CRISPR-Cas9 for Gene Therapy of Inflammatory Bowel Disease

Lin, S., Han, S., Wang, X., Wang, X., Shi, X., He, Z., Sun, M., & Sun, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c07750 · Cited by 46

Nanomedicine for cancer patient‐centered care

Sorrentino, C., Ciummo, S. L., Fieni, C., & Carlo, E. D. (2024) · MedComm · doi:10.1002/mco2.767 · Cited by 43

Recent advances and challenges in colorectal cancer: From molecular research to treatment

Qi, G., Zhao, R., Gao, C., Ma, Z., Wang, S., & Xu, J. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i21.106964 · Cited by 40

A Dual‐Enzyme–Responsive DNA‐Based Nanoframework Enables Controlled Co‐Delivery of CRISPR‐Cas9 and Antisense Oligodeoxynucleotide for Synergistic Gene Therapy

Song, N., Chu, Y., Li, S., Fan, X., Tang, J., Li, H., Tao, R., Li, F., Li, J., Yang, D., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202306634 · Cited by 36

Nanocarriers for intracellular co-delivery of proteins and small-molecule drugs for cancer therapy

Cheng, Z., Li, Y., Zhao, D., Zhao, W., Wu, M., Zhang, W., Cui, Y., Zhang, P., & Zhang, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.994655 · Cited by 35

CRISPR/Cas9: a powerful tool in colorectal cancer research

Hu, Y., Liu, L., Jiang, Q., Fang, W., Chen, Y., Hong, Y., & Zhai, X. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02901-z · Cited by 33

Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy

Li, Z., Pan, Y., Du, S., Li, Y., Chen, C., Song, H., Wu, Y., Luan, X., Xu, Q. H., Guan, X., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.06.016 · Cited by 31

Tumor-overexpressed enzyme responsive amphiphiles small molecular self-assembly nano-prodrug for the chemo-phototherapy against non-small-cell lung cancer

Liu, P., Huang, Y. X., Zhan, C., Zhang, F., Deng, C., Jia, Y., Wan, T. Y., Wang, S., & Li, B. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100722 · Cited by 31

High‐Throughput Screening of Surface Engineered Cyanine Nanodots for Active Transport of Therapeutic Antibodies into Solid Tumor

Qin, Y., Wang, G., Chen, L., Sun, Y., Yang, J., Piao, Y., Shen, Y., & Zhou, Z. (2023) · Advanced Materials · doi:10.1002/adma.202302292 · Cited by 31

Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment

Zhou, S., Li, Y., Wu, Q., & Gong, C. (2024) · MedComm – Biomaterials and Applications · doi:10.1002/mba2.70 · Cited by 30

Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery

Tang, X., Wang, Z., Zhang, Y., Mu, W., & Han, X. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.135116 · Cited by 30

Hepatocyte-confined CRISPR/Cas9-based nanocleaver precisely eliminates viral DNA for efficient and safe treatment of hepatitis B virus infection

Kong, H., Zhuo, C., Yi, K., Zheng, C., Mintz, R. L., Lao, Y., Zhong, Q., Ju, E., Wang, H., Shao, D., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.102040 · Cited by 29

Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges

Dang, Q., Zuo, L., Hu, X., Zhou, Z., Chen, S., Liu, S., Ba, Y., Zuo, A., Xu, H., Weng, S., et al. (2024) · Cancer Medicine · doi:10.1002/cam4.70041 · Cited by 27

Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles

Zhu, M., Wang, X., Xie, R., Wang, Y., Xu, X., Burger, J. C., & Gong, S. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c21683 · Cited by 25

Strategies of nanomedicine for targeting the signaling pathways of Colorectal cancer

Habeeb, M., You, H. W., Aher, K. B., Bhavar, G. B., Khot, V. S., & Mishra, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104487 · Cited by 24

Efficient intracellular and in vivo delivery of toxin proteins by a ROS-responsive polymer for cancer therapy

Lv, J., Yang, Z., Wang, C., Duan, J., Ren, L., Rong, G., Feng, Q., Li, Y., & Cheng, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.064 · Cited by 22

Cascade‐Responsive “Oxidative Stress Amplifiers” Simultaneously Destroy Lysosomes and Co‐Deliver CRISPR/Cas9 to Enhance Oxidative Damage in Tumor

Liang, Y., Han, W., Xu, C., Wang, J., Zhang, J., An, J., Liu, W., Liu, J., Zhang, Z., Shi, J., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202301256 · Cited by 22

Supramolecular Genome Editing: Targeted Delivery and Endogenous Activation of CRISPR/Cas9 by Dynamic Host‐Guest Recognition

Li, B., Li, Q., Qi, Z., Li, Z., Yan, X., Chen, Y., Xu, X., Pan, Q., Chen, Y., Huang, F., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202316323 · Cited by 21

Colorectal cancer cell exosome and cytoplasmic membrane for homotypic delivery of therapeutic molecules

Jarak, I., Santos, A. I., Pinto, A. H., Domingues, C., da Silva, I. S., Melo, R., Veiga, F., & Figueiras, A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123456 · Cited by 20

CRISPR‐Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment

Fard, G. B., Ahmadi, M. H., Gholamin, M., Amirfakhrian, R., Teimourian, E. S., Karimi, M. A., & Bafghi, M. H. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28603 · Cited by 20

Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer

Ren, S.-N., Zhang, Z.-Y., Guo, R.-J., Wang, D., Chen, F., Chen, X., & Fang, X. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i13.1911 · Cited by 19

Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy

Zhang, Y., Zhang, Y., Song, J., Cheng, X., Zhou, C., Huang, S., Zhao, W., Zong, Z., & Yang, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111876 · Cited by 19

Connecting the dots: LncRNAs in the KRAS pathway and cancer

Maqbool, M., Hussain, M. S., Bisht, A. S., Kumari, A., Kamran, A., Sultana, A., Kumar, R., Khan, Y., & Gupta, G. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155570 · Cited by 19

Boronate Building Blocks for Intracellular Protein Delivery

Ren, Q., Cheng, Y., & Lv, J. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202049 · Cited by 18

CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy

Pu, Y., Wu, W., Xiang, H., Chen, Y., & Xu, H. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101734 · Cited by 18

Therapeutic potential of gene therapy for gastrointestinal diseases: Advancements and future perspectives

Yue, N.-N., Xu, H., Xu, J., Zhu, M., Zhang, Y., Tian, C., Nie, Y., Yao, J., Liang, Y.-J., Li, D., et al. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.08.007 · Cited by 18

Histidine-Rich Protein Accelerates the Biomineralization of Zeolitic Imidazolate Frameworks for In Vivo Protein Delivery

Zheng, Q., Sheng, J., Liu, J., Chen, X., & Wang, M. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00706 · Cited by 16

CRISPR /Cas gene editing and delivery systems for cancer therapy

Li, Y., Zhou, S., Wu, Q., & Gong, C. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1938 · Cited by 16

Nanomaterials in gene therapy and genome editing: challenges and emerging directions

Jiang, M., Zhang, K., Wang, Z., Gao, M., Su, S., He, J., Xu, H., Bo, Z., Jiang, Z., Zhang, C., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03895-w · Cited by 14

Calcium phosphate-based nanomedicine mediated CRISPR/Cas9 delivery for prostate cancer therapy

Wei, C., Zhang, R., Wei, L.-Y., Pan, P., Zu, H., Liu, Y.-Z., Wang, Y., & Shen, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1078342 · Cited by 14

Potential roles of hyaluronic acid in in vivo CAR T cell reprogramming for cancer immunotherapy

Laomeephol, C., Areecheewakul, S., Tawinwung, S., Suppipat, K., Chunhacha, P., Neves, N. M., & Luckanagul, J. A. (2022) · Nanoscale · doi:10.1039/d2nr05949e · Cited by 14

Rational Engineering of Cytosolic Delivery Systems for Protein Therapeutics

Lv, J., Liu, X., Yin, L., & Cheng, Y. (2024) · Accounts of Materials Research · doi:10.1021/accountsmr.4c00149 · Cited by 13

A Semiconducting Polymer NanoCRISPR for Near-Infrared Photoactivatable Gene Editing and Cancer Gene Therapy

Liu, Y., Li, F., Lyu, Y., Wang, F., Lee, L. T. O., He, S., Guo, Z., & Li, J. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c00285 · Cited by 13

Improving the use of CRISPR/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine

Fatima, H., Singh, D., Muhammad, H., Acharya, S., & Aziz, M. A. (2024) · 3 Biotech · doi:10.1007/s13205-024-04186-1 · Cited by 12

Post cross-linked ROS-responsive poly(β-amino ester)-plasmid polyplex NPs for gene therapy of EBV-associated nasopharyngeal carcinoma

Yuan, C., Chang, S.-Y., Zhang, C., Dong, D., Ding, J., Mahdavian, A. R., Hu, Z., Sun, L., & Tan, S. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02926c · Cited by 12

Impact of Stimuli-Responsiveness on the mRNA Delivery Efficiency of Low-Generation Dendrimer Nanogels

Xiao, X., Gao, Y., Jia, Y., Shen, M., Pich, A., & Shi, X. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c01272 · Cited by 10

Synthetic nanoparticles for the delivery of CRISPR/Cas9 gene editing system: classification and biomedical applications

Zheng, Q., Wang, W., Zhou, Y., Mo, J., Chang, X., Zha, Z., & Zha, L. (2023) · Biomaterials Science · doi:10.1039/d3bm00788j · Cited by 10

Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation

Wang, Y., Chen, C., Xiao, X. H., Kang, Y., He, J., Beloqui, A., & Xu, Y. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115741 · Cited by 9

The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers

Andrade, F., German-Cortés, J., Montero, S., Carcavilla, P., Baranda-Martínez-Abascal, D., Moltó‐Abad, M., Seras‐Franzoso, J., Díaz‐Riascos, Z. V., Rafael, D. F. D. S., & Abasolo, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061686 · Cited by 9

The role of apoptosis and its potential as a therapeutic target in inflammatory bowel disease associated with colorectal cancer

Zhang, C. (2025) · American Journal of Translational Research · doi:10.62347/ncff5626 · Cited by 7

Nanomedicine for colorectal cancer therapy by remodeling the immune microenvironment

Wu, Y., Su, Y., Wei, Y., Shui, M., Li, W., Yang, L., & Luo, K. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114915 · Cited by 6

Free carrier-enhanced Bi/Bi2S3 nanoparticles enable precise OCT catheter-guided interventional photothermal therapy for colorectal cancer

Huang, X., Yang, F., Gao, B., Ge, W., Gao, L., Wu, J., Tu, S., & Wang, F. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.04.018 · Cited by 6

Transforming Albumin into a Trojan Horse of Immunotherapy-Resistant Colorectal Cancer with a High Microsatellite Instability

Yang, W., Li, Z., Li, Y., He, W., & Yan, J. (2024) · ACS Nano · doi:10.1021/acsnano.4c05893 · Cited by 5

One-pot synthesis of dynamically cross-linked polymers for serum-resistant nucleic acid delivery

Sun, Z., Ren, M., Shan, B., Yang, Q., Zhao, Z., Liu, X., & Yin, L. (2023) · Biomaterials Science · doi:10.1039/d3bm00685a · Cited by 5

DPA-Zn enables targeting and bypassing endosomal trapping delivery of a genome-editing system into cancer cells via phosphatidylserine-mediated endocytic pathway

Shao, Q., Shen, C. ‐. J., You, W., Nie, X., Huang, W., Gao, F., Zhou, X., Wang, L., Wang, L.-H., Chen, G., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155596 · Cited by 4

Convergent Arrangement of sgRNA and Cas9 in CRISPRsome for Transcellular Trafficking

Wang, Y., Zheng, X., Liu, J., Chen, Q., & Zhao, Y. (2022) · ACS Materials Letters · doi:10.1021/acsmaterialslett.2c00064 · Cited by 3

Guanidyl-rich α-helical polypeptide enables efficient cytosolic pro-protein delivery and CRISPR-Cas9 genome editing

Zhao, Z., Zhang, H., Li, W., Wang, Y., Wang, Y., He, Y., Yin, L., & Liu, X. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb02009j · Cited by 2

Supramolecular Genome Editing: Targeted Delivery and Endogenous Activation of CRISPR/Cas9 by Dynamic Host‐Guest Recognition

Li, B., Li, Q., Qi, Z., Li, Z., Yan, X., Chen, Y., Xu, X., Pan, Q., Chen, Y., Huang, F., et al. (2024) · Angewandte Chemie · doi:10.1002/ange.202316323 · Cited by 2

Could Drug Delivery Systems Be Enhancers for Therapy against KRAS-driven Cancers?

Khusnutdinov, R. (2024) · Reviews and Advances in Chemistry · doi:10.1134/s2634827624600312 · Cited by 2

Telomerase-activated Au@DNA nanomachine for targeted chemo-photodynamic synergistic therapy

Zhou, Y., Zhang, J., Cao, D., Tang, A., & Kong, D. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00379e · Cited by 2

Nanoengineering Systems for Gene Therapy: Mechanisms, Modalities, and Future Directions

Mais, R., Kumar, A., Ahmetaj, A. A., Burgos-Crespo, G., Sanchez, M. M., Roxas, D., Dcosta, C., Ilyas, A., Hadjiargyrou, M., & Zanganeh, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135988 · Cited by 1

Applications of CRISPR technology

Du, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23865-9.00003-4

Advances in Nucleic Acid Drug Delivery Systems for Liver Cancer Treatment

Liu, W., Li, D., Deng, K., Liu, J., Zhang, J., & Zhang, C. Y. (2024) · 化学学报 · doi:10.6023/a24090258

Establishing and Utilising In Vitro Lung Models to Demonstrate Peptide Mediated Non-Viral Delivery

Smith, L. (2022) · Nottingham ePrints (University of Nottingham)

Precision oncology in colorectal cancer: Integrating molecular subtyping, multidisciplinary management, and emerging therapeutics

Yang, Y., Cao, H., Xu, Z., Dai, Y., Dai, X., Shao, M., Yao, Y., & He, S. (2026) · Clinical Surgical Oncology · doi:10.1016/j.cson.2026.100119

Reversing the Malignant Proliferation and Doxorubicin Resistance in Human Triple Negative Breast Cancer Cell Line MDA-MB-231 by CRISPR/Cas9-Mediated Deletion of the KISS1R Gene

Puna, W. (2025) · Tuwhera (Auckland University of Technology)

The epigenetic and genetic mechanisms of colorectal cancer pathogenesis

ZHANG, Z.-Y., Li, Y., Rong, D. E. N. G., Jia-Le, C. H. E. N., & Yan-Long, L. I. (2026) · Shengming kexue · doi:10.3724/cbls.2026061

A Narrative Review of the Research Advances in CRISPR/Cas9 for the Treatment of Solid Tumors

Liao, Q. (2026) · Journal of medicine and health science. · doi:10.62517/jmhs.202605105

Sequentially Self-Assembled Supramolecular Nanocomplexes Enable Systemic Cas9 RNP Delivery and In Vivo Tumor Genome Editing

Matsuo, T., Honda, Y., Chino, T., Nomoto, T., Osakabe, Y., Miura, Y., & Nishiyama, N. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c14858

Advanced gene editing technologies for oncology mechanisms, applications, and clinical implementation

Bindu, S., Ash, A., & Sarkar, K. (2026) · Cancer Gene Therapy · doi:10.1038/s41417-026-01070-3

CRISPR/Cas9 technology in oncology: mechanisms, applications, and future perspectives

Абдурахманович, О. М., Karacheva, E. I., Arapieva, M. M., Ulyumdzhiev, K. S., Deiko, V. A., & Муллаянович, Б. И. (2026) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20260403

Statistical, Block, and Gradient Copolymers Reveal Microstructure-Dependent Binding and Intracellular Delivery of Genome Editor Proteins

Sekar, R. P., Lawson, J. L., Camacho, A. N., Werneth, A., Jordan, K., Paruchuri, A., & Kumar, R. (2026) · ACS Polymers Au · doi:10.1021/acspolymersau.6c00169

Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy

Wan, T. Y., Chen, Y., Pan, Q., Xu, X., Kang, Y., Gao, X., Huang, F., Wu, C., & Yuan, P. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.015 · Cited by 117

CRISPR/Cas9 in colorectal cancer: Revolutionizing precision oncology through genome editing and targeted therapeutics.

Alhasso, B., Shareef, A., Baldaniya, L., Oweis, R. J., Jyothi, R., Singh, U., Sahoo, S., Chauhan, A. S., Sameer, H. N., Yaseen, A., et al. (2025) · PubMed Central · doi:10.22038/ijbms.2025.87531.18902 · Cited by 1

Theoretical Analysis of Genome Therapy Colon Cancer via CRISPR-Cas9Preprint

KIMOGLOU, D. (2026) · doi:10.17605/osf.io/rbkw7

Abstract 1826: CRISPR mediated KRAS mutant gene editing in pancreatic and colorectal cancer therapy

Divita, G., Czuba, E., Guidetti, M., Gunenberger, A., Tempremant, L., Josserand, V., & Desai, N. P. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-1826 · Cited by 1

A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer

Jin, J., Li, Y., Deng, F., Yang, L., Lin, Y., Yang, C., Dai, W., Zhang, H., He, B., Zhang, Q., et al. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102291 · Cited by 7